Christian Ottensmeier

I love to have fun with science - mainly trying to understand how the immune system ticks. I love to cook (with my boys), read and go walking with friends

[Christian Ottensmeier @c_ottensmeier]

... and preclinical collaboration with teams in UCL, Cambridge, and of course CRUK who funded the clinical trial and the Amgen team who made drug available.

[Christian Ottensmeier @c_ottensmeier]

it is also an amazing team effort: surgical and medical oncologists from our head and neck center, a multi center clinical collaboration with our friends in Poole, Southampton, Glasgow, amazing scientists in the La Jolla institute...

[Christian Ottensmeier @c_ottensmeier]

We are super happy that our Nature paper went public yesterday. Please find the open access paper at: https://t.co/RV5RXzI1ba

we believe that this is potentially a really big step on how to make combination immunotherapy better for more patients.

[Christian Ottensmeier @c_ottensmeier]

https://t.co/q4KHFiEUN3

[Christian Ottensmeier @c_ottensmeier]

This study was an important step in our collaboration with Transgene, and an early phase clinical trial of personalised immunotherapy in patients with head and neck cancer. https://t.co/D8uonw9wq0

[Christian Ottensmeier @c_ottensmeier]

We are very proud to report that our study "Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer" has been published in the Journal for ImmunoTherapy of Cancer.

[Christian Ottensmeier @c_ottensmeier]

@drjompatterson @CKerawala @nikki_rou @rebeccarandles4 @livHeadandNeck @HeadNeckNorth @HeadNeckCEN Congratulations. Fantastic news.

[Christian Ottensmeier @c_ottensmeier]

https://t.co/9Ey5PE8APT

our story in T follicular regulatory cells recognised by AICR - very proud

[Christian Ottensmeier @c_ottensmeier]

@dalevim @bicops @ACPGBI @Dukes_Club @ESCP_studies @CSSANZ2 @ASCRS_1 Congratulations Dale to you and the team. Amazing work

[Christian Ottensmeier @c_ottensmeier]

Read this #preprint on @researchsquare: Immunomodulatory effects of PI3Kδ inhibition in solid tumors – evaluation in a randomized phase II trial https://t.co/tvmOjIk6PJ

[Christian Ottensmeier @c_ottensmeier]

@wanderer_jasnah :-)

[Christian Ottensmeier @c_ottensmeier]

And here is the link to the paper: https://t.co/xMO6rqq5d6

[Christian Ottensmeier @c_ottensmeier]

@Tinahawke thank you. Hope you are safe and well. Christian

[Christian Ottensmeier @c_ottensmeier]

https://t.co/8YYzKk1KXt

[Christian Ottensmeier @c_ottensmeier]

Joe Sacco, clinician scientist just gave a wonderful talk on his work in immunotherapy in uveal melanoma. Great work, Joe

[Christian Ottensmeier @c_ottensmeier]

@LivHospitals @CCCNHS @livHeadandNeck

[Science Immunology @SciImmunology]

A massive single-cell #RNA sequencing analysis of 80,000+ virus-reactive killer T cells from #COVID19 patients revealed these T cells vary substantially in exhaustion levels depending on disease severity. From @ljiresearch, @livuniITM: https://t.co/HeSwGYAb4q

[Science Immunology @SciImmunology]

A massive single-cell #RNA sequencing analysis of 80,000+ virus-reactive killer T cells from #COVID19 patients revealed these T cells vary substantially in exhaustion levels depending on disease severity. From @ljiresearch, @livuniITM: https://t.co/HeSwGYAb4q

[Christian Ottensmeier @c_ottensmeier]

@livHeadandNeck @MTsalavouta @LivHospitals

[Laban Lab, H&N Cancer Immunology @Labanlabgroup]

New paper published in @IntJCanc analyzing immune checkpoint expression on different immune cell subsets during curative treatment of head and neck squamous cell carcinoma.
https://t.co/Fj0DXLSR4Z
#GRK2254 #ImmunoChatter #cancerresearch #hnscc
@dfg_public @CancerResearch

[Laban Lab, H&N Cancer Immunology @Labanlabgroup]

New paper published in @IntJCanc analyzing immune checkpoint expression on different immune cell subsets during curative treatment of head and neck squamous cell carcinoma.
https://t.co/Fj0DXLSR4Z
#GRK2254 #ImmunoChatter #cancerresearch #hnscc
@dfg_public @CancerResearch